Mark P. Lappe
Founder, Chief Executive Officer
The Inhibrx Management Team
Mark P. Lappe
Founder, Chief Executive Officer
Brendan P. Eckelman, Ph.D.
Founder, EVP Chief Scientific Officer
Quinn Deveraux, Ph.D.
Founder
Kelly Deck, C.P.A.
EVP, Chief Financial Officer
Ashraf Amanullah, Ph.D.
EVP, Chief Technical Operations Officer
David Matly, M.B.A.
EVP, Chief Commercial and Business Development Officer
Jeffrey Jensen
EVP, Chief Clinical Operations Officer
Josep Garcia, Ph.D.
EVP, Chief Clinical Development Officer
Carlos Bais, Ph.D.
EVP, Translational Sciences
Leah Pollema, J.D.
VP, General Counsel
David Kao, PharmD, M.B.A., RPh
VP, Regulatory Affairs
Vasily Andrianov, M.D.
VP, Clinical Science
Robert Boothroyd, PharmD
VP, Medical Affairs and Business Development
Dana Ebbets-Reed, Ph.D.
VP, Quality Assurance
Darren Brown, Ph.D.
VP, Analytical Development and Quality Control
Brian Lobo, Ph.D.
VP, Formulation Development and Drug Product Manufacturing
Charbel Helaihel, PharmD
VP, Marketing and Commercial Planning
Melissa Masterson
VP, Value, Access and Distribution
The Inhibrx Board
Mark P. Lappe
Chairman
Douglas G. Forsyth
Director
Jon Faiz Kayyem, Ph.D.
Director
Kimberly Manhard
Director
Kristiina Vuori, M.D., Ph.D.
Director